文献速递中毒与环境急症心脑血管急症重症综合管理与镇静镇痛

乌头碱中毒室性心律失常的处理

The management of ventricular dysrhythmia in aconite poisoning.
PubMed 文献 · Clin Toxicol (Phila) · 2017-02-20
一句话结论基于65例人病例报告,氟卡尼或胺碘酮似更常与恢复窦性心律相关,延长心肺复苏和体外循环应被视为「买时间」策略。

本文聚焦乌头碱中毒所致室性心律失常(室性早搏、室速、尖端扭转性室速、室颤)的处理。通过检索PubMed和Google Scholar 1966年至2016年7月的英文文献,最终纳入65例可能乌头碱中毒并出现室性心律失常的病例报告。65例中54例发生室速、6例尖端扭转性室速、15例室颤、10例室性早搏、1例未特指的宽QRS波心动过速,10例死亡(死亡率15%)。共实施147次治疗,作者评估46次与成功恢复窦性心律相关;氟卡尼7例中6例终止心律失常,美西律3例中3例纠正,普鲁卡因胺2例中2例恢复窦性心律,延长心肺复苏15例中9例恢复窦性心律,胺碘酮20例中11例成功,体外循环6例中4例恢复窦性心律,硫酸镁9例中2例终止心律失常,直接电复律30例中5例恢复窦性心律。作者认为氟卡尼或胺碘酮似比利多卡因和/或电复律更常与恢复窦性心律相关,但不能确定治疗是否导致窦性心律恢复。

要点

  • 65例乌头碱中毒室性心律失常病例中,54例发生室速、15例室颤、6例尖端扭转性室速,10例死亡(死亡率15%)。
  • 氟卡尼7例中6例、美西律3例中3例、普鲁卡因胺2例中2例与心律失常终止或恢复窦性心律相关。
  • 胺碘酮20例中11例成功纠正心律失常,但动物研究未观察到胺碘酮的潜在有益效应。
  • 延长心肺复苏15例中9例、体外循环6例中4例恢复窦性心律,作者认为应作为「买时间」策略。
  • 直接电复律30例中仅5例恢复窦性心律,硫酸镁9例中仅2例终止心律失常。

适用人群与场景

  • 可能摄入乌头碱并出现室性心律失常的人病例报告患者,共65例。
  • 排除标准包括:乌头暴露未导致室性心律失常、不确定是否摄入乌头、合并摄入其他药物、治疗信息不足或结局信息不足。

诊断标准与关键阈值

  • 室性心律失常类型包括室性早搏、室性心动过速、尖端扭转性室速、室颤及未特指的宽QRS波心动过速;每种心律失常视为独立,同一患者可有多种心律失常。

处置流程与药物剂量

  • 氟卡尼给药7例中6例与心律失常终止相关。
  • 美西律给药3例中3例与心律失常纠正相关。
  • 普鲁卡因胺给药2例中2例与恢复窦性心律相关。
  • 胺碘酮给药20例中11例与成功纠正心律失常相关。
  • 延长心肺复苏15例中9例与恢复窦性心律相关。
  • 体外循环6例中4例与恢复窦性心律相关。
  • 肾上腺素使用4例中2例与恢复窦性心律相关。
  • 硫酸镁给药9例中2例与心律失常终止相关。

红旗征与不能漏的情况

  • 室性心动过速、尖端扭转性室速、室颤及未特指的宽QRS波心动过速均可出现,且可能致命。
  • 65例中10例死亡,死亡率15%。

研究设计与关键结果

  • 本综述纳入65例可能乌头碱中毒并出现室性心律失常的人病例报告;54例发生室速、6例尖端扭转性室速、15例室颤、10例室性早搏、1例未特指的宽QRS波心动过速。
  • 65例共接受147次治疗,作者评估46次干预与成功恢复窦性心律相关。
  • 仅3篇论文提供毒代动力学数据,室性心律紊乱的存在与血浆乌头碱浓度直接相关。
  • 作者结论认为氟卡尼或胺碘酮似比利多卡因和/或电复律更常与恢复窦性心律相关,但不能确定给药是否导致窦性心律恢复。

证据类型、等级与局限

  • 证据类型:聚焦综述,纳入65例人病例报告。
  • 作者指出动物研究未观察到胺碘酮的潜在有益效应,可能与物种间离子通道差异或乌头碱超越心律失常的心血管毒性有关。
  • 局限性:不能确定药物治疗是否影响心律失常病程;不能确定治疗是否导致窦性心律恢复。

对床旁实践的改变

  • 作者认为基于人病例报告证据,氟卡尼或胺碘酮似比利多卡因和/或电复律更常与恢复窦性心律相关。
  • 作者认为延长心肺复苏和体外循环应被视为良好临床护理的组成部分,作为「买时间」策略让机体排泄毒性生物碱。
  • 作者认为美西律、普鲁卡因胺和硫酸镁可能也有作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Aconite poisoning is relatively rare but is frequently complicated by ventricular dysrhythmias, which may be fatal. Molecular basis of aconite alkaloid ventricular arrhythmogenicity: Aconite exerts its toxic effects due to the presence of an admixture of alkaloids present in all parts of the plant. The major target of these aconite alkaloids is the fast voltage-gates sodium channel, where they cause persistent activation. This blockade of the channel in the activated state promotes automaticity within the ventricular myocardium and the generation of ventricular arrhythmias. Aconitine-induced arrhythmias: Aconite alkaloids are known to cause many different types of disturbance of heart rhythm. However, this focused review specifically looks at ventricular rhythm disturbances, namely ventricular ectopy, ventricular tachycardia, torsades des pointes and ventricular fibrillation.

OBJECTIVE: The objective of this review was to identify the outcome of anti-dysrhythmic strategies from animal studies and case reports in humans in order to guide the management of ventricular dysrhythmias in aconite poisoning in humans.

METHODS: A review of the literature in English was conducted in PubMed and Google Scholar from 1966 to July 2016 using the search terms "aconite/aconitine"; "aconite/aconitine + poisoning" and "aconite/aconitine + dysrhythmia". 168 human case-reports and case-series were identified by these searches, of which 103 were rejected if exposure to aconite did not result in ventricular dysrhythmias, if it was uncertain as to whether aconite had been ingested, if other agents were co-ingested, if there was insufficient information to determine the type of treatments administered or if there was insufficient information to determine outcome. Thus, 65 case reports of probable aconite poisoning that resulted in ventricular dysrhythmias were identified. Toxicokinetic data in aconite poisoning: Data were only available in three papers; the presence of ventricular rhythm disturbances directly correlated with the concentration of aconite alkaloids in the plasma.

MANAGEMENT: 54 of 65 cases developed ventricular tachycardia, six developed torsades des pointes, 15 patients developed ventricular fibrillation, 10 developed ventricular ectopics and one developed a broad complex tachycardia not otherwise specified; each dysrhythmia was regarded as separate and patients may have had more than one dysrhythmia. 10 patients died, giving a mortality of 15%. In total, 147 treatments were administered to 65 patients. 46 of the interventions were assessed by the authors as having been associated with successful restoration of sinus rhythm. Flecainide administration was accompanied by dysrhythmia termination in six of seven cases. Mexiletine was connected with correcting dysrhythmias in 3 of 3 cases. Procainamide administration was associated with return to sinus rhythm in 2 of 2 cases. Prolonged cardio-pulmonary resuscitation was administered to 15 patients where it was associated with a return to sinus rhythm in nine of these. Amiodarone was linked to success in correcting dysrhythmias in 11 of 20 cases. Cardiopulmonary bypass use was associated with a return to sinus rhythm in four out of six cases. Epinephrine was documented as being employed on four occasions, and was associated with a restoration of sinus rhythm on two of these. Magnesium sulphate administration was accompanied by dysrhythmia termination in two of nine cases. Direct cardioversion was associated with a return of sinus rhythm in 5 of 30 cases. However, it is not certain whether the drug treatment influenced the course of the dysrhythmia.

CONCLUSIONS: Based on the evidence available from human case reports, flecainaide or amiodarone appear to be more associated with a return to sinus rhythm than lidocaine and/or cardioversion, although it is not established whether the administration of treatment caused reversion to normal sinus rhythm. The potential beneficial effects of amiodarone were not observed in animal studies. This may be due to intra-species differences between ion channels or relate to the wider cardiovascular toxicity of aconite that extends beyond arrhythmias. Prolonged cardiopulmonary resuscitation and cardiopulmonary bypass should be considered as an integral part of good clinical care as "time-buying" strategies to allow the body to excrete the toxic alkaloids. There may also be a role for mexiletine, procainamide and magnesium sulphate.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Coulson JM, Caparrotta TM, Thompson JP, et al. The management of ventricular dysrhythmia in aconite poisoning. Clin Toxicol (Phila). 2017. PMID: 28421842. doi:10.1080/15563650.2017.1291944

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。